Perturbations of the ISG15 pathway have been reported in tumors of the bladder [20], ovary [21], prostate [22], breast [23, 24], and oral squamous tissue [25], and the downregulation of ISG15 expression has been shown to be associated with tumor progression [20]. Here, ISG15 is linked to urinary bladder neoplasm.